CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Fabrizio Vincenzi

OPENALEX: A5059087776↗ORCID: 0000-0002-5027-1699↗

Affiliations

Organizations

University of Ferraraauthorship · IT

Public evidence

4 connected articles

Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition.2022 · Europe PMC Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets.2022 · Europe PMC Cannabigerol Action at Cannabinoid CB<sub>1</sub> and CB<sub>2</sub> Receptors and at CB<sub>1</sub>-CB<sub>2</sub> Heteroreceptor Complexes.2018 · Europe PMC Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB<sub>2</sub> Receptors.2017 · Europe PMC

Registered research

Connected studies

Efficacy and Safety of Hemp-derived, Full Spectrum Cannabigerol (CBG) in Adultsnct05743985

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Fabrizio Vincenzi - Medical Cannabis Research Engine